Is there a role for probiotics in the prevention of preterm birth?

Frontiers in Immunology

Volumn 6, Issue FEB, 2015, Pages

  Yang, Siwen ^a,b   Reid, Gregor ^c,d   Challis, John R G ^a,e   Kim, Sung O ^c,d   Gloor, Gregory B ^c   Bocking, Alan D ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Bacterial vaginosis; Cytokines; Infection and inflammation; Preterm birth; Probiotics; Vaginal microbiome

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ARACHIDONIC ACID; CLINDAMYCIN; CORTICOTROPIN RELEASING FACTOR; GELATINASE B; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; ISOMERASE; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MATRIX METALLOPROTEINASE; METRONIDAZOLE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL COLLAGENASE; PROBIOTIC AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; RANTES; SIALIDASE; STROMELYSIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

AMNION FLUID; BIFIDOBACTERIUM; CHORIOAMNIONITIS; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; LACTOBACILLUS; META ANALYSIS (TOPIC); MYCOPLASMA; NONHUMAN; PREECLAMPSIA; PREGNANT WOMAN; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; SIGNAL TRANSDUCTION; VAGINA FLORA; VAGINITIS;

EID: 84926652801     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00062     Document Type: Short Survey

References (127)

1. Makhseed M, Raghupathy R, El-Shazly S, Azizieh F, Al-Harmi JA, Al-Azemi MM. Pro-inflammatory maternal cytokine profile in preterm delivery. Am J Reprod Immunol (2003) 49:308-18. doi: 10.1034/j.1600-0897.2003.00038.x
2. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet (2008) 371:75-84. doi:10.1016/S0140-6736(08)60074-4
3. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med (2000) 342:1500-7. doi:10.1056/NEJM200005183422007
4. Timmons BC, Reese J, Socrate S, Ehinger N, Paria BC, Milne GL, et al. Prostaglandins are essential for cervical ripening in LPS-mediated preterm birth but not term or antiprogestin-driven preterm ripening. Endocrinology (2014) 155:287-98. doi:10.1210/en.2013-1304
5. Shoji T, Yoshida S, Mitsunari M, Miyake N, Tsukihara S, Iwabe T, et al. Involvement of p38 MAP kinase in lipopolysaccharide-induced production of pro-and anti-inflammatory cytokines and prostaglandin E(2) in human choriodecidua. J Reprod Immunol (2007) 75:82-90. doi:10.1016/j.jri.2007.05.002
6. Romero R, Durum S, Dinarello CA, Oyarzun E, Hobbins JC, Mitchell MD. Interleukin-1 stimulates prostaglandin biosynthesis by human amnion. Prostaglandins (1989) 37:13-22. doi:10.1016/0090-6980(89)90028-2
7. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF III, Petraglia F. Inflammation and pregnancy. Reprod Sci (2009) 16:206-15. doi:10.1177/1933719108329095
8. Olgun NS, Reznik SE. The matrix metalloproteases and endothelin-1 in infection-associated preterm birth. Obstet Gynecol Int (2010) 2010:657039. doi:10.1155/2010/657039
9. Maymon E, Romero R, Pacora P, Gomez R, Mazor M, Edwin S, et al. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection. J Perinat Med (2001) 29:308-16. doi:10.1515/JPM.2001.044
10. Fujimoto T, Parry S, Urbanek M, Sammel M, Macones G, Kuivaniemi H, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem (2002) 277:6296-302. doi:10.1074/jbc.M107865200
11. Park KH, Chaiworapongsa T, Kim YM, Espinoza J, Yoshimatsu J, Edwin S, et al. Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity. J Perinat Med (2003) 31:12-22. doi:10.1515/JPM.2003.002
12. Tency I. Inflammatory response in maternal serum during preterm labour. Facts Views Vis Obgyn (2014) 6:19-30.
13. Yoon BH, Oh SY, Romero R, Shim SS, Han SY, Park JS, et al. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol (2001) 185:1162-7. doi:10.1067/mob.2001.117678
14. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol (2007) 50:652-83. doi:10.1097/GRF.0b013e31811ebef6
15. Buhimschi CS, Dulay AT, Abdel-Razeq S, Zhao G, Lee S, Hodgson EJ, et al. Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. BJOG (2009) 116:257-67. doi:10.1111/j.1471-0528.2008.01925.x
16. Pacora P, Chaiworapongsa T, Maymon E, Kim YM, Gomez R, Yoon BH, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med (2002) 11:18-25. doi:10.1080/jmf.11.1.18.25
17. Pavcnik-Arnol M, Lucovnik M, Kornhauser-Cerar L, Premru-Srsen T, Hojker S, Derganc M, et al. Lipopolysaccharide-binding protein as marker of fetal inflammatory response syndrome after preterm premature rupture of membranes. Neonatology (2014) 105:121-7. doi:10.1159/000356735
18. Goldenberg RL, Andrews WW, Goepfert AR, Faye-Petersen O, Cliver SP, Carlo WA, et al. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol (2008) 198: 43.e1-5. doi:10.1016/j.ajog.2007.07.033
19. Gravett MG, Hitti J, Hess DL, Eschenbach DA. Intrauterine infection and preterm delivery: evidence for activation of the fetal hypothalamic-pituitary-adrenal axis. Am J Obstet Gynecol (2000) 182:1404-13. doi:10.1067/mob.2000.106180
20. Challis JR, Sloboda DM, Alfaidy N, Lye SJ, Gibb W, Patel FA, et al. Prostaglandins and mechanisms of preterm birth. Reproduction (2002) 124(1):1-17. doi:10.1530/rep.0.1240001
21. Farage M, Maibach H. Lifetime changes in the vulva and vagina. Arch Gynecol Obstet (2006) 273:195-202.1. doi:10.1007/s00404-005-0079-x
22. Spear GT, French AL, Gilbert D, Zariffard MR, Mirmonsef P, Sullivan TH, et al. Human alpha-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus. J Infect Dis (2014) 210(7):1019-28. doi:10.1093/infdis/jiu231
23. Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Nikita L, et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome (2014) 2:4. doi:10.1186/2049-2618-2-4
24. Cauci S, Driussi S, De Santo D, Penacchioni P, Iannicelli T, Lanzafame P, et al. Prevalence of bacterial vaginosis and vaginal flora changes in peri-and postmenopausal women. J Clin Microbiol (2002) 40:2147-52. doi:10.1128/JCM.40.6.2147-2152.2002
25. Gupta S, Kumar N, Singhal N, Kaur R, Manektala U. Vaginal microflora in postmenopausal women on hormone replacement therapy. Indian J Pathol Microbiol (2006) 49:457-61.
26. Hummelen R, Macklaim JM, Bisanz JE, Hammond JA, McMillan A, Vongsa R, et al. Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS One (2011) 6:e26602. doi:10.1371/journal.pone.0026602
27. Othman M, Neilson JP, Alfirevic Z. Probiotics for preventing preterm labour. Cochrane Database Syst Rev (2007) 1:CD005941. doi:10.1002/14651858.CD005941.pub2
28. Aagaard K, Riehle K, Ma J, Segata N, Mistretta TA, Coarfa C, et al. A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS One (2012) 7:e36466. doi:10.1371/journal.pone.0036466
29. Chaban B, Links MG, Jayaprakash TP, Wagner EC, Bourque DK, Lohn Z, et al. Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle. Microbiome (2014) 2:23. doi:10.1186/2049-2618-2-23
30. Lamont RF, Sobel JD, Akins RA, Hassan SS, Chaiworapongsa T, Kusanovic JP, et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG (2011) 118:533-49. doi:10.1111/j.1471-0528.2010.02840.x
31. Verstraelen H, Verhelst R, Claeys G, Temmerman M, Vaneechoutte M. Culture-independent analysis of vaginal microflora: the unrecognized association of Atopobium vaginae with bacterial vaginosis. Am J Obstet Gynecol (2004) 191:1130-2. doi:10.1016/j.ajog.2004.04.013
32. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med (2005) 353:1899-911. doi:10.1056/NEJMoa043802
33. Gloor GB, Hummelen R, Macklaim JM, Dickson RJ, Fernandes AD, MacPhee R, et al. Microbiome profiling by illumina sequencing of combinatorial sequence-tagged PCR products. PLoS One (2010) 5:e15406. doi:10.1371/journal.pone.0015406
34. Walther-Antonio MR, Jeraldo P, Berg Miller ME, Yeoman CJ, Nelson KE, Wilson BA, et al. Pregnancy's stronghold on the vaginal microbiome. PLoS One (2014) 9:e98514. doi:10.1371/journal.pone.0098514
35. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A (2011) 108(Suppl 1):4680-7. doi:10.1073/pnas.1002611107
36. Verstraelen H, Verhelst R, Claeys G, De Backer E, Temmerman M, Vaneechouttee M, et al. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol (2009) 9:116. doi:10.1186/1471-2180-9-116
37. Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Bieda J, et al. The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term. Microbiome (2014) 2:18. doi:10.1186/2049-2618-2-18
38. Schwebke JR, Muzny CA, Josey WE. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a conceptual model. J Infect Dis (2014) 210:338-43. doi:10.1093/infdis/jiu089
39. van de Wijgert JH, Borgdorff H, Verhelst R, Crucitti T, Francis S, Verstraelen H, et al. The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One (2014) 9:e105998. doi:10.1371/journal.pone.0105998
40. Donders GG, Van Calsteren K, Bellen G, Reybrouck R, Van den Bosch T, Riphagen I, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG (2009) 116:1315-24. doi:10.1111/j.1471-0528.2009.02237.x
41. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol (2003) 189:1202-8. doi:10.1067/S0002-9378(03)00495-2
42. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 29:297-301.
43. Hummelen R, Fernandes AD, Macklaim JM, Dickson RJ, Changalucha J, Gloor GB, et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One (2010) 5:e12078. doi:10.1371/journal.pone.0012078
44. Jakobsson T, Forsum U. Lactobacillus iners: a marker of changes in the vaginal flora? J Clin Microbiol (2007) 45:3145. doi:10.1128/JCM.00558-07
45. Menard JP, Fenollar F, Henry M, Bretelle F, Raoult D. Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis (2008) 47:33-43. doi:10.1086/588661
46. Ugwumadu AH. Bacterial vaginosis in pregnancy. Curr Opin Obstet Gynecol (2002) 14:115-8. doi:10.1086/588661
47. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev (2007) 1:CD000262. doi:10.1002/14651858.CD000262.pub3
48. Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev (2013) 1:CD000262. doi:10.1002/14651858.CD000262.pub4
49. Smayevsky J, Canigia LF, Lanza A, Bianchini H. Vaginal microflora associated with bacterial vaginosis in nonpregnant women: reliability of sialidase detection. Infect Dis Obstet Gynecol (2001) 9:17-22. doi:10.1155/S1064744901000047
50. Aroutcheva A, Ling Z, Faro S. Prevotella bivia as a source of lipopolysaccharide in the vagina. Anaerobe (2008) 14:256-60. doi:10.1016/j.anaerobe.2008.08.002
51. Mitchell C, Marrazzo J. Bacterial vaginosis and the cervicovaginal immune response. Am J Reprod Immunol (2014) 71:555-63. doi:10.1111/aji.12264
52. Macklaim JM, Fernandes AD, Di Bella JM, Hammond JA, Reid G, Gloor GB. Comparative meta RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome (2013) 1:12. doi:10.1186/2049-2618-1-12
53. Wen A, Srinivasan U, Goldberg D, Owen J, Marrs CF, Misra D, et al. Selected vaginal bacteria and risk of preterm birth: an ecological perspective. J Infect Dis (2014) 209:1087-94. doi:10.1093/infdis/jit632
54. Nelson DB, Hanlon A, Nachamkin I, Haggerty C, Mastrogiannis DS, Liu C, et al. Early pregnancy changes in bacterial vaginosis-associated bacteria and preterm delivery. Paediatr Perinat Epidemiol (2014) 28:88-96. doi:10.1111/ppe.12106
55. Hyman RW, Fukushima M, Jiang H, Fung E, Rand L, Johnson B, et al. Diversity of the vaginal microbiome correlates with preterm birth. Reprod Sci (2014) 21:32-40. doi:10.1177/1933719113488838
56. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J, et al. The placenta harbors a unique microbiome. Sci Transl Med (2014) 6:237ra265. doi:10.1126/scitranslmed.3008599
57. Wilczynski JR. Th1/Th2 cytokines balance-yin and yang of reproductive immunology. Eur J Obstet Gynecol Reprod Biol (2005) 122:136-43. doi:10.1016/j.ejogrb.2005.03.008
58. Esplin MS, Peltier MR, Hamblin S, Smith S, Fausett MB, Dildy GA, et al. Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor. Placenta (2005) 26:661-71. doi:10.1016/j.placenta.2004.09.012
59. Hamilton SA, Tower CL, Jones RL. Identification of chemokines associated with the recruitment of decidual leukocytes in human labour: potential novel targets for preterm labour. PLoS One (2013) 8:e56946. doi:10.1371/journal.pone.0056946
60. El-Bastawissi AY, Williams MA, Riley DE, Hitti J, Krieger JN. Amniotic fluid interleukin-6 and preterm delivery: a review. Obstet Gynecol (2000) 95:1056-64. doi:10.1016/S0029-7844(00)00875-9
61. Hitti J, Hillier SL, Agnew KJ, Krohn MA, Reisner DP, Eschenbach DA, et al. Vaginal indicators of amniotic fluid infection in preterm labor. Obstet Gynecol (2001) 97:211-9. doi:10.1016/S0029-7844(00)01146-7
62. Jun JK, Yoon BH, Romero R, Kim M, Moon JB, Ki SH, et al. Interleukin 6 determinations in cervical fluid have diagnostic and prognostic value in preterm premature rupture of membranes. Am J Obstet Gynecol (2000) 183:868-73. doi:10.1067/mob.2000.109034
63. Coultrip LL, Lien JM, Gomez R, Kapernick P, Khoury A, Grossman JH. The value of amniotic fluid interleukin-6 determination in patients with preterm labor and intact membranes in the detection of microbial invasion of the amniotic cavity. Am J Obstet Gynecol (1994) 171:901-11. doi:10.1016/S0002-9378(94)70057-5
64. von Minckwitz G, Grischke EM, Schwab S, Hettinger S, Loibl S, Aulmann M, et al. Predictive value of serum interleukin-6 and-8 levels in preterm labor or rupture of the membranes. Acta Obstet Gynecol Scand (2000) 79:667-72. doi:10.1034/j.1600-0412.2000.079008667.x
65. Holst RM, Hagberg H, Wennerholm UB, Skogstrand K, Thorsen P, Jacobsson B. Prediction of microbial invasion of the amniotic cavity in women with preterm labour: analysis of multiple proteins in amniotic and cervical fluids. BJOG (2011) 118:240-9. doi:10.1111/j.1471-0528.2010.02765.x
66. Chaiworapongsa T, Romero R, Kim JC, Kim YM, Blackwell SC, Yoon BH, et al. Evidence for fetal involvement in the pathologic process of clinical chorioamnionitis. Am J Obstet Gynecol (2002) 186:1178-82. doi:10.1067/mob.2002.124042
67. Holst RM, Mattsby-Baltzer I, Wennerholm UB, Hagberg H, Jacobsson B. Interleukin-6 and interleukin-8 in cervical fluid in a population of Swedish women in preterm labor: relationship to microbial invasion of the amniotic fluid, intra-amniotic inflammation, and preterm delivery. Acta Obstet Gynecol Scand (2005) 84:551-7. doi:10.1111/j.0001-6349.2005.00708.x
68. Torbe A, Czajka R, Kordek A, Rzepka R, Kwiatkowski S, Rudnicki J. Maternal serum proinflammatory cytokines in preterm labor with intact membranes: neonatal outcome and histological associations. Eur Cytokine Netw (2007) 18:102-7. doi:10.1684/ecn.2007.0092
69. Bowen JM, Chamley L, Mitchell MD, Keelan JA. Cytokines of the placenta and extra placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta (2002) 23:239-56. doi:10.1053/plac.2001.0781
70. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, Mitchell MD. Cytokines, prostaglandins and parturition-a review. Placenta (2003) 24(Suppl A):S33-46. doi:10.1053/plac.2002.0948
71. Hanna N, Bonifacio L, Weinberger B, Reddy P, Murphy S, Romero R, et al. Evidence for interleukin 10-mediated inhibition of cyclo-oxygenase-2 expression and prostaglandin production in preterm human placenta. Am J Reprod Immunol (2006) 55:19-27. doi:10.1111/j.1600-0897.2005.00342.x
72. Puchner K, Iavazzo C, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D, et al. Mid-trimester amniotic fluid interleukins (IL-1beta, IL-10 and IL-18) as possible predictors of preterm delivery. In vivo (2011) 25:141-8.
73. Vogel I, Goepfert AR, Thorsen P, Skogstrand K, Hougaard DM, Curry AH, et al. Early second-trimester inflammatory markers and short cervical length and the risk of recurrent preterm birth. J Reprod Immunol (2007) 75:133-40. doi:10.1016/j.jri.2007.02.008
74. Ferguson KK, McElrath TF, Chen YH, Mukherjee B, Meeker JD. Longitudinal profiling of inflammatory cytokines and C-reactive protein during uncomplicated and preterm pregnancy. Am J Reprod Immunol (2014) 72:326-36. doi:10.1111/aji.12265
75. Menon R, Torloni MR, Voltolini C, Torricelli M, Merialdi M, Betran AP, et al. Biomarkers of spontaneous preterm birth: an overview of the literature in the last four decades. Reprod Sci (2011) 18:1046-70. doi:10.1177/1933719111415548
76. Bhat G, Williams SM, Saade GR, Menon R. Biomarker interactions are better predictors of spontaneous preterm birth. Reprod Sci (2014) 21:340-50. doi:10.1177/1933719113497285
77. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev (2004) 17:259-75. doi:10.1079/NRR200479
78. Roberfroid M. Prebiotics: the concept revisited. J Nutr (2007) 137:830s-7s.
79. Watson D, O'Connell Motherway M, Schoterman MH, van Neerven RJ, Nauta A, van Watson D, et al. Selective carbohydrate utilization by lactobacilli and bifidobacteria. J Appl Microbiol (2013) 114:1132-46. doi:10.1111/jam.12105
80. Ben XM, Li J, Feng ZT, Shi SY, Lu YD, Chen R, et al. Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal bifidobacteria and Lactobacilli. World J Gastroenterol (2008) 14:6564-8. doi:10.3748/wjg.14.6564
81. Song SK, Beck BR, Kim D, Park J, Kim J, Kim HD, et al. Prebiotics as immunostimulants in aquaculture: a review. Fish Shellfish Immunol (2014) 40:40-8. doi:10.1016/j.fsi.2014.06.016
82. Kubota T, Shimojo N, Nonaka K, Yamashita M, Ohara O, Igoshi Y, et al. Prebiotic consumption in pregnant and lactating women increases IL-27 expression in human milk. Br J Nutr (2014) 111:625-32. doi:10.1017/S0007114513003036
83. Otsuki K, Tokunaka M, Oba T, Nakamura M, Shirato N, Okai T. Administration of oral and vaginal prebiotic lactoferrin for a woman with a refractory vaginitis recurring preterm delivery: appearance of lactobacillus in vaginal flora followed by term delivery. J Obstet Gynaecol Res (2014) 40:583-5. doi:10.1111/jog.12171
84. Myhre R, Brantsaeter AL, Myking S, Eggesbo M, Meltzer HM, Haugen M, et al. Intakes of garlic and dried fruits are associated with lower risk of spontaneous preterm delivery. J Nutr (2013) 143:1100-8. doi:10.3945/jn.112.173229
85. FAO/WHO. Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food. London, ON (2001). Available from: ftp://ftp.fao.org/docrep/fao/009/a0512e/a0512e00.pdf.
86. Chen AC, Chung MY, Chang JH, Lin HC. Pathogenesis implication for necrotizing enterocolitis prevention in preterm very-low-birth-weight infants. J Pediatr Gastroenterol Nutr (2014) 58:7-11. doi:10.1097/MPG.0b013e3182a7dc74
87. Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev (2013) 5:CD006095. doi:10.1002/14651858.CD006095.pub3
88. Yang Y, Guo Y, Kan Q, Zhou XG, Zhou XY, Li Y, et al. A meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Braz J Med Biol Res (2014) 47:804-10. doi:10.1590/1414-431X20143857
89. Grin PM, Kowalewska PM, Alhazzan W, Fox-Robichaud AE. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol (2013) 20:6607-14.
90. Szajewska H, Guandalini S, Morelli L, Van Goudoever JB, Walker A. Effect of Bifidobacterium animalis subsp lactis supplementation in preterm infants: a systematic review of randomized controlled trials. J Pediatr Gastroenterol Nutr (2010) 51:203-9. doi:10.1097/MPG.0b013e3181dc0d93
91. Reid G, Brigidi P, Burton JP, Contractor N, Duncan S, Fargier E, et al. Microbes central to human reproduction. Am J Reprod Immunol (2014) 73(1):1-11. doi:10.1111/aji.12319
92. Bodean O, Munteanu O, Cirstoiu C, Secara D, Cirstoiu M. Probiotics-α helpful additional therapy for bacterial vaginosis. J Med Life (2013) 6:434-6.
93. Homayouni A, Bastani P, Ziyadi S, Mohammad-Alizadeh-Charandabi S, Ghalibaf M, Mortazavian AM, et al. Effects of probiotics on the recurrence of bacterial vaginosis: a review. J Low Genit Tract Dis (2014) 18:79-86. doi:10.1097/LGT.0b013e31829156ec
94. Nishijima K, Shukunami K, Kotsuji F. Probiotics affects vaginal flora in pregnant women, suggesting the possibility of preventing preterm labor. J Clin Gastroenterol (2005) 39:447-8. doi:10.1097/01.mcg.0000159269.58480.4b
95. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol (2003) 35:131-4. doi:10.1016/S0928-8244(02)00465-0
96. Martinez RC, Franceschini SA, Patta MC, Quintana SM, Gomes BC, De Martinis EC, et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol (2009) 55:133-8. doi:10.1139/w08-102
97. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect (2006) 8:1450-4. doi:10.1016/j.micinf.2006.01.003
98. Lindsay KL, Brennan L, McAuliffe FM. Acceptability of and compliance with a probiotic capsule intervention in pregnancy. Int J Gynaecol Obstet (2014) 125:279-80. doi:10.1016/j.ijgo.2014.01.004
99. Dugoua JJ, Machado M, Zhu X, Chen X, Koren G, Einarson TR, et al. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. J Obstet Gynaecol Can (2009) 31:542-52.
100. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol (2001) 32:37-41. doi:10.1111/j.1574-695X.2001.tb00531.x
101. Morelli L, Zonenenschain D, Del Piano M, Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol (2004) 38(6 Suppl):S107-10. doi:10.1097/01.mcg.0000128938.32835.98
102. Vallor AC, Antonio MA, Hawes SE, Hillier SL. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis (2001) 184(11):1431-6. doi:10.1086/324445
103. Baeten JM, Hassan WM, Chohan V, Richardson BA, Mandaliya K, Ndinya-Achola JO, et al. Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women. Sex Transm Infect (2009) 85(5):348-53. doi:10.1136/sti.2008.035451
104. Mirmonsef P, Hotton AL, Gilbert D, Burgad D, Landay A, Weber KM, et al. Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH. PLoS One (2014) 9(7):e102467. doi:10.1371/journal.pone.0102467
105. Donati L, Di Vico A, Nucci M, Quagliozzi L, Spagnuolo T, Labianca A, et al. Vaginal microbial flora and outcome of pregnancy. Arch Gynecol Obstet (2010) 281:589-600. doi:10.1007/s00404-009-1318-3
106. O'Hanlon DE, Moench TR, Cone RA. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One (2013) 8:e80074. doi:10.1007/s00404-009-1318-3
107. Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet (2014) 289:479-89. doi:10.1007/s00404-013-3064-9
108. Cadieux P, Burton J, Gardiner G, Braunstein I, Bruce AW, Kang CY, et al. Lactobacillus strains and vaginal ecology. JAMA (2002) 287:1940-1. doi:10.1001/jama.287.15.1935
109. Petrova MI, van den Broek M, Balzarini J, Vanderleyden J, Lebeer S. Vaginal microbiota and its role in HIV transmission and infection. FEMS Microbiol Rev (2013) 37:762-92. doi:10.1111/1574-6976.12029
110. Kemgang TS, Kapila S, Shanmugam VP, Kapila R. Cross-talk between probiotic lactobacilli and host immune system. J Appl Microbiol (2014) 117:303-19. doi:10.1111/jam.12521
111. Kim SO, Sheikh HI, Ha SD, Martins A, Reid G. G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages. Cell Microbiol (2006) 8:1958-71. doi:10.1111/j.1462-5822.2006.00763.x
112. Yeganegi M, Leung CG, Martins A, Kim SO, Reid G, Challis JR, et al. Lactobacillus rhamnosus GR-1 stimulates colony-stimulating factor 3 (granulocyte) (CSF3) output in placental trophoblast cells in a fetal sex-dependent manner. Biol Reprod (2011) 84:18-25. doi:10.1095/biolreprod.110.085167
113. Yeganegi M, Leung CG, Martins A, Kim SO, Reid G, Challis JR, et al. Lactobacillus rhamnosus GR-1 induced IL-10 production in human placental trophoblast cells involves activation of JAK/STAT and MAPK pathways. Reprod Sci (2010) 17:1043-51. doi:10.1177/1933719110377237
114. Yeganegi M, Watson CS, Martins A, Kim SO, Reid G, Challis JR, et al. Effect of Lactobacillus rhamnosus GR-1 supernatant and fetal sex on lipopolysaccharide-induced cytokine and prostaglandin-regulating enzymes in human placental trophoblast cells: implications for treatment of bacterial vaginosis and prevention of preterm labor. Am J Obstet Gynecol (2009) 200(532):e531-8. doi:10.1016/j.ajog.2008.12.032
115. Yang S, Li W, Challis JR, Reid G, Kim SO, Bocking AD. Probiotic Lactobacillus rhamnosus GR-1 supernatant prevents lipopolysaccharide-induced preterm birth and reduces inflammation in pregnant CD-1 mice. Am J Obstet Gynecol (2014) 211: 44.e1-44.e12. doi:10.1016/j.ajog.2014.01.029
116. Mileti E, Matteoli G, Iliev ID, Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One (2009) 4:e7056. doi:10.1371/journal.pone.0007056
117. Gardiner GE, Heinemann C, Bruce AW, Beuerman D, Reid G. Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diagn Lab Immunol (2002) 9:92-6. doi:10.1128/CDLI.9.1.92-96.2002
118. Kirjavainen PK, Laine RM, Carter D, Hammond J-A, Reid G. Expression of anti microbial defense factors in vaginal mucosa following exposure of Lactobacillus rhamnosus GR-1. Int J Probiotics (2008) 3:99-106.
119. Timmerman HM, Niers LE, Ridwan BU, Koning CJ, Mulder L, Akkemans LM, et al. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr (2007) 26:450-9. doi:10.1016/j.clnu.2007.04.008
120. Ruiz FO, Gerbaldo G, Garcia MJ, Giordano W, Pascual L, Barberis IL, et al. Synergistic effect between two bacteriocin-like inhibitory substances produced by lactobacilli strains with inhibitory activity for Streptococcus agalactiae. Curr Microbiol (2012) 64:349-56. doi:10.1007/s00284-011-0077-0
121. Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J, et al. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A (2005) 102:10321-6. doi:10.1073/pnas.0504084102
122. Claes IJ, Lebeer S, Shen C, Verhoeven TL, Dilissen E, De Hertogh G, et al. Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin Exp Immunol (2010) 162:306-14. doi:10.1111/j.1365-2249.2010.04228.x
123. Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E, et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A (2011) 108(Suppl 1):4623-30. doi:10.1073/pnas.1005066107
124. Li W, Yang S, Kim SO, Reid G, Challis JR, Bocking AD. Lipopolysaccharide-induced profiles of cytokine, chemokine, and growth factors produced by human decidual cells are altered by Lactobacillus rhamnosus GR-1 supernatant. Reprod Sci (2014) 21:939-47. doi:10.1177/1933719113519171
125. Lin YP, Thibodeaux CH, Pena JA, Ferry GD, Versalovic J. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm Bowel Dis (2008) 14:1068-83. doi:10.1002/ibd.20448
126. Bermudez-Brito M, Munoz-Quezada S, Gomez-Llorente C, Romero F, Gil A. Lactobacillus rhamnosus and its cell-free culture supernatant differentially modulate inflammatory biomarkers in Escherichia coli-challenged human dendritic cells. Br J Nutr (2014) 111:1727-37. doi:10.1017/S0007114513004303
127. Krauss-Silva L, Moreira ME, Alves MB, Braga A, Camacho KG, Batista MR, et al. A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results. Trials (2011) 12:239. doi:10.1186/1745-6215-12-239